Rainbow Childrens Medicare profit and loss

Latest FY26

Revenue: ₹1,703cr+12.4% on FY25
EBITDA: ₹544cr+11.1% on FY25
Net profit: ₹282cr+15.3% on FY25
EPS: ₹27.41+14.4% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Expenses
	1,820	1,703	1,516	1,297	1,174	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	36.5	43.8	51.0	37.1	30.9
	1,857	1,747	1,567	1,334	1,204
	244	227	195	165	158
	249	234	206	176	144
	80.7	77.6	72.5	59.1	55.2
	159	151	138	112	90.3
	752	698	625	527	475
	1,484	1,387	1,237	1,039	923
	575	544	490	429	396
	417	394	351	317	306
Profit
	372	360	330	295	282
	−1.5	−1.5	0.0	0.0	0.0
	371	358	330	295	282
	101	96.1	89.3	77.0	84.1
	−20.8	−19.4	−3.5	−0.5	−14.7
	80.5	76.7	85.8	76.5	69.4
	290	282	244	218	212
	290	282	244	218	212
	−0.9	−0.7	−0.1	1.3	0.4
	289	281	244	220	213
	285	278	243	217	211
	4.9	3.2	0.8	1.3	1.5
Per share
	₹28.11	₹27.41	₹23.97	₹21.38	₹20.89
	₹28.11	₹27.41	₹23.84	₹21.38	₹20.89
Other comprehensive income — detail
	−0.9	−0.7	−0.1	—	—
	−1.2	−1.0	−0.1	1.8	0.6
	−0.3	−0.2	−0.0	—	—
	—	—	—	0.4	0.1
	285	278	243	218	211
	4.9	3.2	0.8	1.3	1.5
Per share — as-filed variants
	₹28.11	₹27.41	₹23.97	₹21.38	₹20.89
	₹28.11	₹27.41	₹23.84	₹21.38	₹20.89
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	1,576	1,476	1,321	1,132	1,015
	86.6%	86.7%	87.1%	87.3%	86.5%
Adjusted (ex-exceptional items) — derived
	372	360	330	295	282
	−1.5	−1.5	0.0	0.0	0.0
	291	283	244	218	212
	₹28.23	₹27.53	₹23.97	₹21.38	₹20.89

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

RAINBOW₹1,196.80

Rainbow Childrens Medicare Ltd.

· Pharma & Health

Annual Quarterly₹ CrorePeersAPOLLOHOSP FORTIS KIMS POLYMED PFIZER ONESOURCE JUBLPHARMA VIJAYAMcap ₹12,155 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Revenue from Operations	1,173.6	1,296.9	1,515.9	1,703.1	1,820.1
Other Income	30.9	37.1	51.0	43.8	36.5
Total Income	1,204.4	1,334.0	1,566.9	1,746.9	1,856.6
Expenses
+ Cost of Materials Consumed	158.3	165.3	194.9	227.0	244.1
+ Employee Benefit Expense	144.1	176.2	206.4	233.5	248.8
+ Finance Costs	55.2	59.1	72.5	77.6	80.7
+ Depreciation & Amortisation	90.3	112.1	138.4	150.6	158.6
+ Other Expenses	474.9	526.6	624.7	698.4	752.1
Total Expenses	922.7	1,039.2	1,236.9	1,387.1	1,484.3
EBITDA	396.4	428.9	489.9	544.2	575.2
EBIT	306.1	316.8	351.4	393.6	416.6
Profit
PBT before Exceptional Items	281.8	294.8	330.0	359.8	372.3
+ Exceptional Items	0.0	0.0	0.0	-1.5	-1.5
Pretax Income	281.8	294.8	330.0	358.2	370.8
+ Current Tax	84.1	77.0	89.3	96.1	101.3
+ Deferred Tax	-14.7	-0.5	-3.5	-19.4	-20.8
Tax Expense	69.4	76.5	85.8	76.7	80.5
Net Income	212.4	218.3	244.2	281.5	290.3
+ Net Income — Continuing Ops	212.4	218.3	244.2	281.5	290.3
+ Other Comprehensive Income	0.4	1.3	-0.1	-0.7	-0.9
Total Comprehensive Income	212.8	219.6	244.2	280.8	289.4
Net Income to Common	210.8	217.0	243.4	278.3	285.4
Minority Interest	1.5	1.3	0.8	3.2	4.9
Per Share
Basic EPS	20.89	21.38	23.97	27.41	28.11
Diluted EPS	20.89	21.38	23.84	27.41	28.11
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	-0.1	-0.7	-0.9
+ Items NOT to be Reclassified to P&L	0.6	1.8	-0.1	-1.0	-1.2
+ Tax on Items NOT to be Reclassified	—	—	-0.0	-0.2	-0.3
+ Tax on Items NOT to be Reclassified — alt tag	0.1	0.4	—	—	—
Comprehensive Income — Owners of Parent	211.3	218.3	243.3	277.6	284.5
Comprehensive Income — Non-controlling Interests	1.5	1.3	0.8	3.2	4.9
Per Share — as-filed variants
Basic EPS — Continuing Operations	20.89	21.38	23.97	27.41	28.11
Diluted EPS — Continuing Operations	20.89	21.38	23.84	27.41	28.11
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	1,015.3	1,131.6	1,320.9	1,476.0	1,576.1
Gross Margin %	86.51	87.26	87.14	86.67	86.59
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	281.8	294.8	330.0	359.8	372.3
− Exceptional Items (reconciliation)	0.0	0.0	0.0	-1.5	-1.5
Net Income Adj (tax-effected)	212.4	218.3	244.2	282.8	291.5
EPS Adj	20.89	21.38	23.97	27.53	28.23
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00	10.00	10.00
Paid Up Equity Capital	101.5	101.5	101.6	101.6	101.6

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.